DAHANCA 19: A randomized phase III study of primary (chemo-) radiotherapy and zalutumumab in head and neck carcinomas

Jesper Grau Eriksen, Christian Maare, Hanne Primdahl, Jan Evensen, Claus Andrup Kristensen, Lisbeth Juhler Andersen, Jens Overgaard, Jørgen Johansen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Original languageEnglish
Publication date2014
Publication statusPublished - 2014
EventESTRO 33: European Society for Radiotherapy & Oncology Annual Meeting - Wien, Austria
Duration: 4. Apr 20148. Apr 2014

Conference

ConferenceESTRO 33
Country/TerritoryAustria
CityWien
Period04/04/201408/04/2014

Cite this